Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

43.8%

14 terminated/withdrawn out of 32 trials

Success Rate

53.3%

-33.2% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

119%

19 of 16 completed trials have results

Key Signals

19 with results8 terminated6 withdrawn

Enrollment Performance

Analytics

N/A
24(88.9%)
Phase 4
2(7.4%)
Phase 1
1(3.7%)
27Total
N/A(24)
Phase 4(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT04677166Not ApplicableTerminated

Coupling Negative Pressure Wound Therapy With Instillation

Role: collaborator

NCT05902793Not ApplicableCompleted

Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds

Role: lead

NCT00234559Not ApplicableWithdrawn

Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis

Role: lead

NCT00224796Phase 4Completed

Trial of Vacuum Assisted Closure® Therapy in Amputation Wounds of the Diabetic Foot

Role: lead

NCT01016353Completed

Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique

Role: lead

NCT01867580Not ApplicableCompleted

A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement

Role: lead

NCT01831596Not ApplicableTerminated

Evaluation of a Novel Post-Surgical Dressing

Role: lead

NCT01623882Withdrawn

Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

Role: lead

NCT01417208Withdrawn

Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds

Role: lead

NCT01450631Not ApplicableCompleted

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Role: lead

NCT01380665Phase 4Withdrawn

Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty

Role: lead

NCT00432965Not ApplicableCompleted

Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers

Role: lead

NCT00847730Not ApplicableCompleted

Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy

Role: lead

NCT02302222Not ApplicableTerminated

The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing

Role: lead

NCT03274466Not ApplicableCompleted

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

Role: lead

NCT01341444Not ApplicableTerminated

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects

Role: lead

NCT00605189Not ApplicableTerminated

A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies

Role: lead

NCT00837096Not ApplicableTerminated

A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds

Role: lead

NCT03722485Not ApplicableTerminated

Negative Pressure Wound Therapy With Instillation of Saline Solution Versus Collagenase Ointment in Full-thickness Wounds

Role: lead

NCT02836990Not ApplicableCompleted

Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery

Role: collaborator